Pharma companies reduce prices of Remdesivir injections after Centre's intervention

Pharma companies reduce prices of Remdesivir injections after Centre's intervention

Raipur: The price of Remdesivir Injection has been reduced following government’s intervention.

National Pharmaceutical Pricing Authority said, major Pharma companies have announced voluntary price cuts for Remdesivir Injections after Centre's intervention to ensure its affordable availability. Cadila Healthcare's Remdac will now cost Rs 899 instead of Rs 2,800.

Syngene International's RemWin will now cost Rs 2,450 instead of Rs 3,950. Dr Reddy's Redyx will be available at Rs 2,700 instead of Rs 5,400. Cipla's Cipremi will cost Rs 3,000 instead of Rs 4,000. Mylan Pharmaceutical's Desrem will be available at Rs 3,400 instead of Rs 4,800. Jubilant Generic's Jubi-R will now cost Rs 3,400 instead of Rs 4,700. Hetero Healthcare's Covifor will be available at Rs 3,490 instead of Rs 5,400.